1.Efficacy of transurethral plasmakinetic resection of the prostate using a small-caliber resectoscope for benign prostatic hyperplasia with mild urethral stricture.
Zhiwei ZHU ; Zhibiao QING ; Junhuan HE ; Xuecheng WU ; Wuxiong YUAN ; Yixing DUAN ; Yuanwei LI ; Mingqiang ZENG
Journal of Central South University(Medical Sciences) 2024;49(11):1751-1756
OBJECTIVES:
The conventional Fr26 resectoscope is difficult to use in patients with benign prostatic hyperplasia (BPH) complicated by urethral stricture. This study aims to evaluate the safety and efficacy of transurethral plasmakinetic resection of the prostate (PKRP) using a small-caliber (Fr18.5) plasmakinetic resectoscope combined with urethral dilation in patients with BPH and mild urethral stricture.
METHODS:
A retrospective analysis was conducted on 37 patients with BPH and mild urethral stricture treated at the Department of Urology, Hunan Provincial People's Hospital from January 2023 to December 2023. All patients underwent PKRP with a small-caliber plasmakinetic resectoscope, followed by routine placement of a Fr20 three-way Foley catheter for continuous bladder irrigation. International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), post-voiding residual urine volume (PVR), and Quality of Life (QOL) scores were compared before and after surgery. Perioperative indicators (intraoperative bleeding, operative time, postoperative catheterization time, and postoperative hospital stay) and complications were recorded.
RESULTS:
The median age was 69 years, and the median duration of voiding difficulty was 36 months. Median total prostate specific antigen (T-PSA) was 2.095 ng/mL, free prostate specific antigen (F-PSA) 0.561 ng/mL, and F/T ratio 0.3. Median prostate diameter was 48 mm and volume 41 mL. All 37 surgeries were completed successfully: 11 had external meatal stricture, 19 had mild anterior urethral stricture, and 7 had mild posterior urethral stricture (1 patient with a 1 cm pseudo-blind tract near the membranous urethral). Operative time was (2.4±0.7) hours, blood loss was (40±29) mL, median catheterization duration was 7 days, and median hospital stay was 7 days. No cases of postoperative urinary incontinence, recurrent hematuria, or sepsis occurred, and patients were satisfied with the surgical outcome. At 3 to 6 months follow-up, IPSS, Qmax, PVR, and QOL scores significantly improved compared to preoperative levels (all P<0.01), with no cases of urethral stricture progression or new-onset stricture.
CONCLUSIONS
PKRP using a small-caliber plasmakinetic resectoscope is safe and effective for treating BPH with mild urethral stricture. It offers advantages such as minimal trauma, rapid postoperative recovery, and a lower risk recovery, and a lower risk of aggravating urethral injury.
Humans
;
Male
;
Prostatic Hyperplasia/complications*
;
Urethral Stricture/complications*
;
Retrospective Studies
;
Aged
;
Transurethral Resection of Prostate/instrumentation*
;
Middle Aged
;
Treatment Outcome
;
Quality of Life
;
Aged, 80 and over
2.Shovel-shaped electrode transurethral plasmakinetic enucleation versus plasmakinetic resection of the prostate in the treatment of benign prostatic hyperplasia.
Lin ZHAO ; Yong-Hong MA ; Qi CHEN ; Yan-Bo CHEN ; Meng GU ; Jing-Feng GAO ; Guang-Tao ZHANG ; Jiang-Ning MOU ; Zhen-Hu BAO ; Zhong WANG
National Journal of Andrology 2018;24(2):133-137
Objective:
To compare the safety and effectiveness of shovel-shaped electrode transurethral plasmakinetic enucleation of the prostate (PKEP) with those of plasmakinetic resection of the prostate (PKRP) in the treatment of benign prostatic hyperplasia (BPH).
METHODS:
We retrospectively analyzed the clinical data about 78 BPH patients received in Shanghai Ninth People's Hospital from June 2016 to January 2017, 39 treated by shovel-shaped electrode PKEP and the other 39 by PKRP. We observed the patients for 6 months postoperatively and compared the effects and safety of the two surgical strategies.
RESULTS:
No statistically significant difference was observed between the PKEP and PKRP groups in the operation time ([69.3 ± 8.8] vs [72.2 ± 7.9] min, P = 0.126), but the former, as compared with the latter, showed a markedly less postoperative loss of hemoglobin ([3.9 ± 2.8] vs [13.9 ± 5.2] g/L, P <0.001) and shorter bladder irrigation time ([12.5 ± 1.2] vs [43.4 ± 2.8] h, P <0.001), catheterization time ([64.0 ± 4.5] vs [84.8 ± 3.0] h, P <0.001) and hospital stay ([3.1 ± 0.3] vs [5.5 ± 0.4] d, P <0.001). There were no statistically significant differences between the PKEP and PKRP groups in the postoperative maximum urinary flow rate (Qmax) ([21.62 ± 1.07] vs [21.03 ± 0.96] ml/s, P = 0.12), International Prostate Symptoms Score (IPSS) (5.85 ± 0.90 vs 6.03 ± 0.81, P = 0.279), quality of life score (QoL) (2.0 ± 0.73 vs 2.28 ± 0.72, P = 0.09), postvoid residual urine volume (PVR) ([19.59 ± 6.01] vs [20.21 ± 5.16] ml, P = 0.629), or the incidence rates of urinary incontinence (2.56% [1/39] vs 7.69% [3/39], P >0.05) and other postoperative complications.
CONCLUSIONS
Both PKEP and PKRP are effective methods for the treatment of BPH, but PKEP is worthier of clinical recommendation for a better safety profile, more thorough removal of the prostate tissue, less blood loss, shorter hospital stay, and better improved quality of life of the patient.
China
;
Electrodes
;
adverse effects
;
Equipment Design
;
Humans
;
Male
;
Prostatic Hyperplasia
;
surgery
;
Quality of Life
;
Retrospective Studies
;
Transurethral Resection of Prostate
;
instrumentation
;
methods
;
Treatment Outcome
3.One day surgery in the treatment of benign prostatic enlargement with thulium laser: A single institution experience.
Luca CARMIGNANI ; Alberto MACCHI ; Dario RATTI ; Elisabetta FINKELBERG ; Stefano CASELLATO ; Serena MARUCCIA ; Carlo MARENGHI ; Stefano Carlo Maria PICOZZI
Korean Journal of Urology 2015;56(5):365-369
PURPOSE: Various articles have previously addressed the introduction of new surgical laser therapies for an enlarged prostate gland causing obstructive symptoms. The objective of this study was to report the feasibility of performing the thulium laser vapo-enucleation of the prostate (ThuVEP) procedure for benign prostatic obstruction in a 1-day surgery. MATERIALS AND METHODS: From September 2011 to September 2013, we conducted a prospective study on patients who underwent ThuVEP in a 1-day surgery. The primary outcomes measured perioperatively included operative time, resected tissue weight, hemoglobin decrease, transfusion rate, postoperative irrigation and catheterization time, and postoperative hospital stay. Also, the preoperative and postoperative International Prostate Symptom Score (IPSS) and results of uroflowmetry performed on the 7th and 30th postoperative days were recorded. All perioperative and postoperative complications were monitored. RESULTS: A total of 53 patients underwent the surgical treatment in a 1-day surgery. Seven patients continued antiaggregant therapy with aspirin. Mean preoperative prostatic adenoma volume was 56.6 mL. Mean operative time was 71 minutes. The average catheter time was 14.8 hours. The peak urinary flow rate on day 7 improved from 9.3 to 17.42 mL/s (p<0.001) and the IPSS improved from 18 to 10.2 (p<0.01). Patients were routinely discharged on the day of catheter removal. No complications were recorded. CONCLUSIONS: ThuVEP can be safely conducted as a 1-day surgical procedure. This strategy results in cost savings. ThuVEP shows good standardized outcomes with respect to improvement in flow parameters and length of bladder catheterization.
Aged
;
Ambulatory Surgical Procedures
;
Humans
;
Laser Therapy/adverse effects/*instrumentation
;
Lasers, Solid-State/*therapeutic use
;
Length of Stay
;
Male
;
Middle Aged
;
Operative Time
;
Prospective Studies
;
Prostate/*surgery
;
Prostatic Hyperplasia/*surgery
;
Thulium/*therapeutic use
;
Transurethral Resection of Prostate
;
Treatment Outcome
5.Advances in minimally invasive treatment of benign prostatic hyperplasia.
National Journal of Andrology 2007;13(8):739-743
The therapeutic options for benign prostatic hyperplasia (BPH) can be divided into medicinal, surgical and minimally invasive treatments. The minimally invasive treatment of BPH is gradually accepted by more and more urologists for its advantages of less damage, good effect, quick recovery and easy acceptance by patients, which includes transurethral needle ablation of the prostate (TUNA), transurethral microwave therapy (TUMT), photoselective laser vaporization of the prostate (PVP), holmium laser enucleation of the prostate (HOLEP) and so on. This article updates the advances in the minimally invasive treatment.
Catheter Ablation
;
Humans
;
Male
;
Minimally Invasive Surgical Procedures
;
instrumentation
;
methods
;
Prostatic Hyperplasia
;
surgery
;
therapy
;
Transurethral Resection of Prostate
;
instrumentation
;
methods
6.Prevention of urethral stricture after transurethral vaporesection of prostate by adjustable urethral tractor.
Bo-dong LU ; Shi-geng ZHANG ; Xiao-jun HUANG
Journal of Zhejiang University. Medical sciences 2006;35(5):564-567
OBJECTIVETo reduce the complication by transurethral vaporesection of prostate (TUVP) using adjustable urethral tractor.
METHODSOne hundred and six cases with benign prostate hypertrophy underwent TUVP and catheter traction after operation by an adjustable tractor. The results by catheter traction were compared with those by rubberized cloth paste and carbasus compression.
RESULTThe urethral stricture occurred in 2.7%, 6.7%, 30.4% of cases by the catheter traction, rubberized cloth paste and carbasus compression respectively, which had statistical significance (P <0.01).
CONCLUSIONThe incidence of urethral stricture can be reduced by catheter traction after TUVP.
Aged ; Humans ; Male ; Middle Aged ; Prostatic Hyperplasia ; surgery ; Traction ; instrumentation ; Transurethral Resection of Prostate ; adverse effects ; Urethral Stricture ; etiology ; prevention & control ; Urinary Catheterization
7.Transurethral Resection of the Prostate with a Bipolar Tissue Management System Compared to Conventional Monopolar Resectoscope: One-Year Outcome.
Chang Jun YOON ; Ji Yoon KIM ; Ki Hak MOON ; Hee Chang JUNG ; Tong Choon PARK
Yonsei Medical Journal 2006;47(5):715-720
The purpose of the present study was to evaluate the efficacy and safety of bipolar transurethral prostatectomy (TURP) using the GyrusTM PlasmaKinetic System compared with conventional monopolar TURP. This study included 102 patients with benign prostatic hyperplasia (BPH) who underwent TURP from January 2003 to March 2005. In all, 49 consecutive patients had bipolar and 53 had monopolar TURP. All patients were assessed by preoperative and postoperative International Prostate Symptom Score (IPSS), uroflowmetry, transrectal ultrasonography, operative time, weight of resected tissue, change in serum sodium and hemoglobin, duration of catheter use, length of hospital stay, and complication rates. Significant improvement was seen postoperatively in both groups, and no difference was observed in the resection time, weight of resected tissue, change in serum sodium and hemoglobin, improvement of IPSS and peak flow rate (Qmax), or complication rates over the 12-month follow-up in both groups. There was, however, a significant difference in duration of catheter use and hospital stay. Duration of catheter use (2.28 days vs. 3.12 days) and hospital stay (3.52 days vs. 4.27 days) were shorter in the bipolar group (p = 0.012 vs. p = 0.034, respectively). Our results demonstrate that bipolar TURP using the Gyrus(TM) Plasma Kinetic System is as effective as conventional monopolar TURP with the additional advantage of reduced length of catheter use and hospital stay. Bipolar TURP is a promising new technique that may prove to be a good alternative to conventional TURP in the future.
Treatment Outcome
;
Transurethral Resection of Prostate/adverse effects/*instrumentation/methods
;
Prostatic Hyperplasia/*surgery
;
Prostate/*surgery
;
Middle Aged
;
Male
;
Humans
;
Follow-Up Studies
;
Equipment and Supplies/standards
;
Aged

Result Analysis
Print
Save
E-mail